technology meets the needs of all skin types by selecting different pulse shapes (S-pulse, D-pulse, H-pulse and U-pulse), which plays an important role in the ablation of the epidermis, and allows for a deeper penetration to the dermis. Furthermore, complete control of duration, energy and shape of each pulse makes it the best solution for the needs of all skin resurfacing treatments. The most striking benefit of the is, indeed, the innovative
SmartXide2
pulse shape that modulate the ablation and the thermal effect (coagulation) in fractional scanning modes, inducing faster recovery time and enhancing patient safety.
Clinical evidence Clinical evidence also supports the benefits of the device on skin rejuvenation. For example, a recent study by Luci1
examined the
effectiveness of the treatment on a young patient with severe polymorphic and bilateral scarring (Figures 1 and 2). The SmartXide2
source was used with a mix of three techniques to obtain an effective remodelling of the scar tissue in just one session, and to cut down the recovery time as well. A surgical handpiece was first
CO2
used freehand to reduce the visibility of the atrophies, levelling the scar margins by controlling the vaporisation depth. A uniform but superficial vaporisation was then performed over the entire treatment area during the same session, to reduce the final dichromatic appearance, using the HiScan DOT/ RF scanning system in traditional resurfacing mode. Lastly, tissue stimulation was carried out with the same scanner in
/RF laser
“Complete control of
duration,
energy and shape of each pulse makes this the best solution for the needs of all skin
resurfacing treatments.
”
fractional mode (laser and bipolar RF current) to produce new collagen. As illustrated in Figure 2, encouraging results were attained after just one outpatient session. It is important to note that it is
possible to reach the desired results in a fast, flexible and efficacious way, thanks to three main components of the SmartXide2
:
■PSD technology ■Free handpiece ■HiScan DOT/RF.
Conclusions The multifunctional features of DEKA’s SmartXide2
system make it
an indispensable device in the world of CO2
lasers. This user-friendly
shorter recovery time of the non-ablative RF source. SmartXide2
device enables physicians to exploit the synergistic action of the ablative fractional CO2
laser with the ,
with the scanning system HiScan DOT/RF, offers physicians a wide range of applications and benefits, consequently
becoming
indispensable in modern medical aesthetic
practices. Most
importantly, patients can greatly benefit from this groundbreaking laser system: outpatient procedure, minimum treatment discomfort (no bleeding, less pain), better tolerance to treatment, and extremely short downtime.
Further information
DEKA is a world-class leader in the design and manufacture of lasers and light system sources for applications in the medical field. DEKA markets its devices through a network of distributors and direct branches, with office in more than 80 countries.
Excellence is the hallmark of DEKA’s experience and recognition garnered in the sphere of R&D. Quality, innovation and technological excellence place DEKA in a unique and distinguished position worldwide.
email:
deka.webcontacts@deka.it website:
www.dekalaser.com
prime-journal.com | March 2012 ❚ 75 Reference
1. Luci, A. White Paper: Treatment of Acne Scars. Rome, Italy: Istituto Dermopatico dellÕImmacolata, 2011
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112